Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DCM is an active private venture capital firm founded in 1996 that invests primarily in early-stage technology companies. The firm operates with a cross-border model spanning the United States and Asia, and focuses on sectors including consumer, enterprise, fintech, frontier technology, and selected healthcare and digital health investments. DCM is not itself a biotech, pharma, or healthcare operating company; rather, it backs startups as a financial investor. Its portfolio has included companies such as Bill.com, SoFi, Matterport, Kuaishou, Figure, Cherry, and Hims & Hers Health. For a biotech analyst, DCM is best understood as a generalist technology VC with some exposure to healthcare-related portfolio companies rather than a life sciences developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DCM Ventures.